FHTX Latest Press Releases

-- October 22, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX PRNewswire 10:01 AM

-- October 11, 2026 --

FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law Business Wire 5:16 PM

-- October 8, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX PRNewswire 10:02 AM

-- October 6, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX Globe Newswire 5:20 PM

-- October 1, 2026 --

Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities Globe Newswire 7:00 AM

-- August 6, 2026 --

Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update Globe Newswire 7:00 AM

-- July 1, 2026 --

Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director Globe Newswire 7:00 AM

-- June 22, 2026 --

Next-Generation DNA Repair Therapies Open New Frontiers in Oncology Globe Newswire 8:30 AM

-- June 5, 2026 --

Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes